Nuzenio

Pacific Biosciences

Pacific Biosciences news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Earnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29 - simplywall.stsimplywall.st · Sat, 08 Aug 2026 14:41:26 GMTPacific Biosciences of California (NASDAQ:PACB) Cut to "Sell" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:32:14 GMTPACB Q2 Deep Dive: Leadership Transition and SPRQ-Nx Rollout Shape Outlook - StockStoryStockStory · Thu, 06 Aug 2026 22:58:55 GMTPACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2026: Revenue $39.01M, EPS ($0.14) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:50:20 GMTTD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3 - MoomooMoomoo · Thu, 06 Aug 2026 18:22:07 GMTPacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 17:04:00 GMTPacBio CEO steps down amid layoffs, widening Q2 loss - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 14:45:21 GMTCustomer success story: How CHU Nîmes went from install to routine rare disease use in three months - PacBioPacBio · Thu, 06 Aug 2026 13:06:20 GMT

Timeline

Sat, 08 Aug 2026 14:41:26 GMTEarnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29 - simplywall.st
Sat, 08 Aug 2026 06:32:14 GMTPacific Biosciences of California (NASDAQ:PACB) Cut to "Sell" at Wall Street Zen - MarketBeat
Thu, 06 Aug 2026 22:58:55 GMTPACB Q2 Deep Dive: Leadership Transition and SPRQ-Nx Rollout Shape Outlook - StockStory
Thu, 06 Aug 2026 21:50:20 GMTPACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2026: Revenue $39.01M, EPS ($0.14) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 18:22:07 GMTTD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Thu, 06 Aug 2026 17:04:00 GMTPacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pacific Biosciences.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.